Allphase Pharma Consulting, LLC
A Professional Service Provider for the Pharma Industry
When Pfizer bought dalbavancin and anidulofungin from Vicuron in 2005, it shelled out USD 1.9 billion for both Phase 3 drugs. One can argue whether each drugs had the same commercial value for Pfizer but it is safe to assume that dalbavancin was valued at approx. USD 1 billion at Continue reading Dalbavancin Sale to Actavis
Chapter 166 [1] in the new Mandell textbook was written before the current Ebola outbreak, so I thought it would be interesting to read View Postit again and check whether the ‘old’ recommendations for personal protection were still valid now that we have learned much more during the ongoing outbreak. In Continue reading Preventing Ebola Transmission
We are told by Tom Frieden / CDC that it was a “protocol breach” when a nurse in Texas taking care of US Ebola patient no. 1 got infected? At the same news conference, he tells us he doesn’t know what kind of breach actually occurred. So what is he talking Continue reading Ebola and “Breach of Protocol”: Makes Me Bristle…